Tamoxifen (Nolvadex) Research in Connecticut | QSC
QSC RESEARCH GRADE — CONNECTICUT
≥99% HPLC PurityMS ConfirmedJanoshik COADomestic USA Shipping
Tamoxifen (Nolvadex) Research — Connecticut
Tamoxifen (Nolvadex) is a Selective Oestrogen Receptor Modulator (SERM) used in research models studying Breast Cancer / ER-positive Tumour Research, Gynecomastia Research, HPG Axis / PCT Research. QSC supplies Tamoxifen to research institutions, university laboratories, and independent researchers across Connecticut with domestic USA shipping and third-party Janoshik COA verification.
About Tamoxifen (Nolvadex)
Tamoxifen is a triphenylethylene SERM. Competitively binds oestrogen receptor alpha (ERα) with high affinity. Tissue-selective: acts as ER antagonist in breast tissue (blocking oestrogen-driven proliferation) but as partial ER agonist in bone and uterus. Metabolised by CYP2D6 to the active 4-hydroxytamoxifen and endoxifen, which have 30–100× higher ERα affinity than tamoxifen itself. Also used in …
QSC operates a domestic USA fulfilment network with 5-region shipping coverage. Orders to Connecticut ship from the nearest domestic hub — typically 3–5 business days. All compounds ship in sealed, temperature-appropriate, discrete packaging with Janoshik COA documentation.
